Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Koji Yanase"'
Publikováno v:
Transactions of the Materials Research Society of Japan. 44:69-73
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4f927e932e3476032c141a6ce995024
https://doi.org/10.14723/tmrsj.44.69
https://doi.org/10.14723/tmrsj.44.69
Publikováno v:
World Academy of Sciences Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::abfda0f59de478c8c9494ffd6c560927
https://doi.org/10.3892/wasj.2020.36
https://doi.org/10.3892/wasj.2020.36
Publikováno v:
Internal Medicine
Both autoimmune hepatitis (AIH) and eosinophilic fasciitis (EF) are known to be complicated by other autoimmune diseases. However, AIH complicated by EF has never been reported. We experienced a 58-year-old man with AIH complicated by EF. He was admi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00cc5a91603b8f7a35a632b4cc3655b3
http://europepmc.org/articles/PMC6443560
http://europepmc.org/articles/PMC6443560
Autor:
Yasuhide Ikenaka, Hiroshi Fukui, Yusaku Shirai, Mitsuteru Kitade, Akitoshi Douhara, Kosuke Kaji, Kei Moriya, Tadashi Namisaki, Koji Yanase, Hitoshi Yoshiji, Yosuke Aihara, Ryuichi Noguchi, Hideto Kawaratani, Junichi Yoshii
Publikováno v:
Journal of Gastroenterology. 49:481-491
Dipeptidyl peptidase-4 inhibitor (DPP4-I) is clinically used as a new oral antidiabetic agent. Although DPP4 is reportedly associated with the progression of chronic liver diseases, the effect of DPP4-I on liver fibrosis development is still obscure.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc159e9972be2d710a88824c39d7b8fd
https://doi.org/10.1007/s00535-013-0783-4
https://doi.org/10.1007/s00535-013-0783-4
Autor:
Koji Yanase, Junichi Yoshii, Tatsuhiro Tsujimoto, Kosuke Kaji, Yasuhide Ikenaka, Mitsuteru Kitade, Ryuichi Noguchi, Yusaku Shirai, Tadashi Namisaki, Hitoshi Yoshiji, Hiroshi Fukui, Yosuke Aihara, Hideto Kawaratani
Publikováno v:
American Journal of Physiology-Gastrointestinal and Liver Physiology. 300:G1094-G1104
Angiotensin II type I receptor blocker and iron chelator reportedly exert suppressive effects on nonalcoholic steatohepatitis (NASH) progression, including liver fibrosis and hepatocarcinogenesis. The aim of this study was to elucidate the combined e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::759694ebd8feebb3b81e720dc9bb549f
https://doi.org/10.1152/ajpgi.00365.2010
https://doi.org/10.1152/ajpgi.00365.2010
Autor:
Hiroshi Fukui, Kosuke Kaji, Mitsuteru Kitade, Yasuhide Ikenaka, Tadashi Namisaki, Hideto Kawaratani, Hitoshi Yoshiji, Tatsuhiro Tsujimoto, Masaharu Yamazaki, Ryuichi Noguchi, Yusaku Shirai, Koji Yanase, Junichi Yoshii
Publikováno v:
Hepatology Research. 40:540-549
Aim The renin-angiotensin-aldosterone system (RAAS) has become known as a prerequisite for tumor angiogenesis, including hepatocellular carcinoma (HCC). Although angiotensin II is known to play an important role in tumor growth and angiogenesis, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c6e594c0d025ccad31b1431355a8d43
https://doi.org/10.1111/j.1872-034x.2010.00636.x
https://doi.org/10.1111/j.1872-034x.2010.00636.x
Autor:
Junichi Yoshi, Kosuke Kaji, Hitoshi Yoshiji, Tadashi Namisaki, Hiroshi Fukui, Koji Yanase, Masaharu Yamazaki, Mitsuteru Kitade, Ryuichi Noguchi, Takemi Akahane, Masahito Uemura, Yasuhide Ikenaka, Tatsuhiro Tsujimoto
Publikováno v:
International Journal of Oncology. 32(1):193-199
Interferon (IFN) is known as a multifunctional cytokine. The aim of this study was to examine the different effects of IFN subclass; namely, IFN-alpha and IFN-beta, on hepatocellular carcinoma (HCC) growth especially in conjunction with angiogenesis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::651d545d9b4d60c59124b1424d39993f
http://hdl.handle.net/10564/2321
http://hdl.handle.net/10564/2321
Autor:
Junichi Yoshii, Koji Yanase, Hiroshi Fukui, Yasuhide Ikenaka, Kosuke Kaji, Hitoshi Yoshiji, Kiyoshi Asada, Shigeki Kuriyama, Tatsuhiro Tsujimoto, Ryuichi Noguchi, Masaharu Yamazaki, Masahito Uemura, Takemi Akahane, Mitsuteru Kitade
Publikováno v:
Hepatology Research. 36:124-129
Both angiotensin-II (AT-II) and vascular endothelial growth factor (VEGF) have been shown to play important roles in the progression of liver fibrosis. However, the interaction of AT-II with VEGF in the liver fibrosis has not been elucidated yet. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a6587e7fc4005b1575655c302fcb767
https://doi.org/10.1016/j.hepres.2006.07.003
https://doi.org/10.1016/j.hepres.2006.07.003
Autor:
Takemi Akahane, Masaharu Yamazaki, Koji Yanase, Tadashi Namisaki, Junichi Yoshii, Masahito Uemura, Hitoshi Yoshiji, Mitsuteru Kitade, Kiyoshi Asada, Kosuke Kaji, Hideyuki Kojima, Ryuichi Noguchi, Yasuhide Ikenaka, Hiroshi Fukui, Tatsuhiro Tsujimoto
Publikováno v:
Hepatology. 44:983-991
Nonalcoholic steatohepatitis (NASH) may cause fibrosis, cirrhosis, and hepatocellular carcinoma (HCC); however, the exact mechanism of disease progression is not fully understood. Angiogenesis has been shown to play an important role in the progressi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::578f219d585d17fa64b4070006dd4ca9
https://doi.org/10.1002/hep.21338
https://doi.org/10.1002/hep.21338
Autor:
Junichi Yoshii, Tadashi Namisaki, Tsutomu Masaki, Yasuhide Ikenaka, Hitoshi Yoshiji, Hiroshi Fukui, Koji Yanase, Shigeki Kuriyama, Masaharu Yamazaki, Ryuichi Noguchi, Mitsuteru Kitade
Publikováno v:
Journal of Hepatology. 42:687-693
Background/Aims Chemoprevention should be a promising approach to improve the prognosis of the patients with hepatocellular carcinoma (HCC). Angiogenesis is now recognized as a crucial step not only in tumor growth, but also in early carcinogenesis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0096f66a9ba338f0a6660802d0a8473f
https://doi.org/10.1016/j.jhep.2004.12.025
https://doi.org/10.1016/j.jhep.2004.12.025